AIM-104

N/A

Report date: 2023/12/08 17:21:17

Base Information

Drug NameAIM-104
Drug Alias NameAIM-104
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Signal-regulatory protein alpha
TargetsSignal-regulatory protein alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApeximmune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesApeximmune Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A